Toleranzia Competitors and Similar CompaniesClear all
Toleranzia's competitors and similar companies include Quantum Hi-Tech (China) Biological, Novartis, Fortrea and Pfizer.
 Toleranzia Toleranzia is a company specializing in preclinical and early clinical drug research for autoimmune diseases. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ||
Founding Date | Founding Date 2011 | Founding Date 2000 | Founding Date 1996 | Founding Date 2023 | Founding Date 1849 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Göteborg, SE HQ | Locations Guang Zhou Shi, CN HQ | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more |
Employees | Employees 10 | Employees 1,814 | Employees 75,883 | Employees 19,000 | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.6 b | Valuation ($) 163.9 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥810m (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit kr1.1m (FY, 2024) | Gross profit ¥320.9m (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit N/A | Gross profit $46.5b (FY, 2025) |
Net income | Net income (kr9.4m) (FY, 2024) | Net income ¥13.6m (FY, 2025) | Net income $14b (FY, 2025) | Net income ($986.2m) (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 90 (Jul, 2023) | Countries 200 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A | Registration Phase Products 5 (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 81.7k | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Quantum Hi-Tech (China) Biological
HQ
Guang Zhou Shi, CN
Employees
1,814
Quantum Hi-Tech (China) Biological is a biotechnology company.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyFortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company